ClinicalTrials.gg
CompletedNCT05710497Updated Nov 8, 2023

Maxillary Vascular Canal Thickness and Sinus Augmentation Bleeding

An observational study in Bone Loss, sponsored by Marmara University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-11-08.

Sponsored by Marmara University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aims to evaluate the relationship between the maxillary intra-osseous vascular canal thickness as measured by volumetric tomography and the amount of intra-operative bleeding during open sinus floor augmentation. A sample of patients will be selected, and their maxillary intra-osseous vascular canal thickness will be measured using volumetric tomography. Intraoperative bleeding will be recorded during open sinus floor augmentation. The data will be analyzed to determine if there is a correlation between the thickness of the maxillary intra-osseous vascular canal and intraoperative bleeding.

02

Conditions studied

  • Bone Loss

Keywords

  • Maxillary Sinus Floor Augmentation
  • Volumetric Computed Tomography
  • Intra-operative bleeding
03

In context

Bone Diseases, Metabolic

487 studies on the registry are indexed under Bone Diseases, Metabolic; 74 are open to participants now.

This study's enrollment of 20 is below the median of 80 across 107 observational studies indexed under Bone Diseases, Metabolic.

Browse Bone Diseases, Metabolic studies →

Lead sponsor

Marmara University is the lead sponsor of 590 studies on the registry; 135 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients who present with the complaint of tooth loss in the posterior region and need rehabilitation with fixed prostheses on implants, whose horizontal bone width is suitable for dental implant placement but sinus floor augmentation will be performed due to insufficient vertical height.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Maxillary partial or total edentulism, including premolar/molar regions
  • Medically healthy
  • 2 to 5 mm residual bone height
  • Sufficient bone width to place a standard dental implant (diameter >4mm)
  • Age: 18-65 years
  • Patients who volunteered to participate in the study and signed written informed consent

Exclusion criteria

Exclusion Criteria:

  • Maxillary sinusitis
  • Acute myocardial infarction in the last 12 months
  • Use of any medication that may inhibit bone healing
  • History of radiotherapy in the head and neck region
  • Presence of psychiatric problems
  • Smoking more than 10 cigarettes a day
  • Alcoholism
  • Chronic drug use
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Total amount of intraoperative bleeding

    After surgery, the total amount of intraoperative bleeding will be calculated in milliliters.

    Time frame: From beginning of surgery to end of surgery

07

Study locations

1 site
  • Marmara University School of Dentistry
    Istanbul, 34854, Turkey (Türkiye)
08

References and documents

Publications

  • Chanavaz M. Sinus grafting related to implantology. Statistical analysis of 15 years of surgical experience (1979-1994). J Oral Implantol. 1996;22(2):119-30. PubMed 9151634 ↗
  • Elian N, Wallace S, Cho SC, Jalbout ZN, Froum S. Distribution of the maxillary artery as it relates to sinus floor augmentation. Int J Oral Maxillofac Implants. 2005 Sep-Oct;20(5):784-7. PubMed 16274154 ↗
  • Mardinger O, Abba M, Hirshberg A, Schwartz-Arad D. Prevalence, diameter and course of the maxillary intraosseous vascular canal with relation to sinus augmentation procedure: a radiographic study. Int J Oral Maxillofac Surg. 2007 Aug;36(8):735-8. doi: 10.1016/j.ijom.2007.05.005. Epub 2007 Jul 12. PubMed 17629462 ↗
  • Rosano G, Taschieri S, Gaudy JF, Del Fabbro M. Maxillary sinus vascularization: a cadaveric study. J Craniofac Surg. 2009 May;20(3):940-3. doi: 10.1097/SCS.0b013e3181a2d77f. PubMed 19461336 ↗
  • Rosano G, Taschieri S, Gaudy JF, Weinstein T, Del Fabbro M. Maxillary sinus vascular anatomy and its relation to sinus lift surgery. Clin Oral Implants Res. 2011 Jul;22(7):711-715. doi: 10.1111/j.1600-0501.2010.02045.x. Epub 2010 Dec 9. PubMed 21143535 ↗
  • Solar P, Geyerhofer U, Traxler H, Windisch A, Ulm C, Watzek G. Blood supply to the maxillary sinus relevant to sinus floor elevation procedures. Clin Oral Implants Res. 1999 Feb;10(1):34-44. doi: 10.1034/j.1600-0501.1999.100105.x. PubMed 10196788 ↗
  • Stern A, Green J. Sinus lift procedures: an overview of current techniques. Dent Clin North Am. 2012 Jan;56(1):219-33, x. doi: 10.1016/j.cden.2011.09.003. PubMed 22117952 ↗
  • Tatum H Jr. Maxillary and sinus implant reconstructions. Dent Clin North Am. 1986 Apr;30(2):207-29. PubMed 3516738 ↗
  • Zijderveld SA, van den Bergh JP, Schulten EA, ten Bruggenkate CM. Anatomical and surgical findings and complications in 100 consecutive maxillary sinus floor elevation procedures. J Oral Maxillofac Surg. 2008 Jul;66(7):1426-38. doi: 10.1016/j.joms.2008.01.027. PubMed 18571027 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05710497
Lead sponsor
Marmara University
Responsible party
Ferit Bayram (Assist. Prof., Marmara University) — Principal investigator
First posted
Feb 2, 2023
Start date
Mar 1, 2023
Primary completion
Nov 1, 2023
Completion
Nov 7, 2023
Last update
Nov 8, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion